Tapewire

NYSE · USD

AMN

AMN HEALTHCARE SERVICES INC

Export transactions ↓
Tapewire entity
4780
SEC CIK
0001142750
Parsed reports
393

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionCommon Stock 196 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 3

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 41 $26.12 $1,070.92
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,144

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:37 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionCommon Stock 138 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000003 · wk-form4_1737142649.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,185

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
GrantRestricted Stock Units · Derivative 20,099 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · derivative · entry 10

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,099

Underlying: Common Stock · 20,099 shares

Expires not disclosed

F9 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F10 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Exercise / conversionRestricted Stock Units · Derivative 2,247 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · derivative · entry 9

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,565

Underlying: Common Stock · 2,247 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Exercise / conversionRestricted Stock Units · Derivative 1,390 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · derivative · entry 8

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,433

Underlying: Common Stock · 1,390 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F7 · derivative.expiration_date: Restricted Stock Units do not have an expiration date

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Exercise / conversionRestricted Stock Units · Derivative 1,373 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · derivative · entry 7

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,373 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Tax withholdingCommon Stock 572 $26.12 $14,940.64
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 6

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,998

F2 · kind: Shares withheld for tax purposes.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Tax withholdingCommon Stock 565 $26.12 $14,757.80
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 5

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,570

F2 · kind: Shares withheld for tax purposes.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Tax withholdingCommon Stock 924 $26.12 $24,134.88
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 4

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,135

F2 · kind: Shares withheld for tax purposes.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Exercise / conversionCommon Stock 2,247 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 3

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Exercise / conversionCommon Stock 1,390 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:35 UTC
Hagan Mark ChristopherChief Information and Digital
Exercise / conversionCommon Stock 1,373 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000002 · wk-form4_1737142550.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,422

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares acquired on the vesting of Restricted Stock Units.

Read SEC document
January 15, 2025 Filed Jan 17, 2025 19:34 UTC GrantRestricted Stock Units · Derivative 26,799 $0.00 $0.00
Disclosure

SEC source: 0001142750-25-000001 · wk-form4_1737142449.xml · derivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,799

Underlying: Common Stock · 26,799 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 18:23 UTC GrantRestricted Stock Units · Derivative 37,009 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000064 · wk-form4_1734459797.xml · derivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,009

Underlying: Common Stock · 37,009 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Performance Restricted Stock Units ("PRSU") identified in this row were granted on December 15, 2024 and will be eligible for vesting based upon the achievement of a performance requirement. The ultimate number of PRSUs that can be deemed earned and vested under this award depends on the absolute total shareholder return for the period beginning on December 15, 2024 and ending on December 31, 2027

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
December 15, 2024 Filed Dec 17, 2024 18:23 UTC GrantRestricted Stock Units · Derivative 37,009 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000064 · wk-form4_1734459797.xml · derivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,009

Underlying: Common Stock · 37,009 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on December 15, 2024 and vest in three tranches on each of the first, second, and third anniversaries of the grant date.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
November 28, 2024 Filed Dec 2, 2024 20:03 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 2,694 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · derivative · entry 6

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,776

Underlying: Common Stock · 2,694 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F7 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
November 28, 2024 Filed Dec 2, 2024 20:03 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 5,389 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · derivative · entry 5

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,552

Underlying: Common Stock · 5,389 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on November 28, 2022 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F7 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
November 28, 2024 Filed Dec 2, 2024 20:03 UTC
Grace CarolineDirector · Chief Executive Officer
Tax withholdingCommon Stock 1,022 $26.29 $26,868.38
Disclosure

SEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · nonDerivative · entry 4

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,752

F3 · kind: Number of shares withheld for tax purposes.

Read SEC document
November 28, 2024 Filed Dec 2, 2024 20:03 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionCommon Stock 2,694 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · nonDerivative · entry 3

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,774

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Common stock acquired on the vesting of restricted stock units.

Read SEC document
November 28, 2024 Filed Dec 2, 2024 20:03 UTC
Grace CarolineDirector · Chief Executive Officer
Tax withholdingCommon Stock 2,121 $26.29 $55,761.09
Disclosure

SEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · nonDerivative · entry 2

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,080

F3 · kind: Number of shares withheld for tax purposes.

Read SEC document
November 28, 2024 Filed Dec 2, 2024 20:03 UTC
Grace CarolineDirector · Chief Executive Officer
Exercise / conversionCommon Stock 5,389 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000063 · wk-form4_1733169773.xml · nonDerivative · entry 1

Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,201

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common stock acquired on the vesting of Restricted Stock Units.

F2 · balance_after: Includes 470 shares of AMN Common Stock purchased pursuant to the AMN Healthcare Employee Stock Purchase Plan ("ESPP") on March 28, 2024 and 164 shares of AMN Common Stock purchased pursuant to the ESPP on September 30, 2024.

Read SEC document
November 02, 2024 Filed Nov 4, 2024 23:22 UTC Exercise / conversionRestricted Stock Units · Derivative 9,950 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000057 · wk-form4_1730762538.xml · derivative · entry 3

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,950 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on November 2, 2021 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
November 02, 2024 Filed Nov 4, 2024 23:22 UTC SaleCommon Stock 2,461 $36.90 $90,810.90
Disclosure

SEC source: 0001142750-24-000057 · wk-form4_1730762538.xml · nonDerivative · entry 2

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,550

F2 · kind: Number of shares withheld for tax purposes.

Read SEC document
November 02, 2024 Filed Nov 4, 2024 23:22 UTC Exercise / conversionCommon Stock 9,950 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000057 · wk-form4_1730762538.xml · nonDerivative · entry 1

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,011

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common stock acquired on the vesting of Restricted Stock Units.

Read SEC document
October 15, 2024 Filed Oct 16, 2024 20:08 UTC Exercise / conversionRestricted Stock Units · Derivative 2,232 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000054 · wk-form4_1729109331.xml · derivative · entry 3

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,534

Underlying: Common Stock · 2,232 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units reflected in this row were granted on October 15, 2023 and vest on the first, second and third anniversary of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
October 15, 2024 Filed Oct 16, 2024 20:08 UTC Tax withholdingCommon Stock 544 $40.19 $21,863.36
Disclosure

SEC source: 0001142750-24-000054 · wk-form4_1729109331.xml · nonDerivative · entry 2

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,061

F3 · kind: Number of shares withheld for tax purposes.

Read SEC document
October 15, 2024 Filed Oct 16, 2024 20:08 UTC Exercise / conversionCommon Stock 2,232 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000054 · wk-form4_1729109331.xml · nonDerivative · entry 1

Knudson Jeffrey R · CIK 0001752946 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,605

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

F2 · balance_after: Includes 218 shares of AMN Common Stock purchased pursuant to the AMN Healthcare Employee Stock Purchase Plan ("ESPP") on March 28, 2024 and 351 shares of AMN Common Stock purchased pursuant to the ESPP on September 30, 2024.

Read SEC document
October 15, 2024 Filed Oct 16, 2024 20:12 UTC
Hagan Mark ChristopherChief Information and Digital
GrantRestricted Stock Units · Derivative 18,661 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000056 · wk-form4_1729109524.xml · derivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,661

Underlying: Common Stock · 18,661 shares

Expires not disclosed

F3 · derivative.exercise_price: Restricted Stock Units do not have an expiration date.

F4 · derivative.exercise_date: The Performance Restricted Stock Units ("PRSU") identified in this row were granted on October 15, 2024 and will be eligible for vesting based upon the achievement of a performance requirement. The ultimate number of PRSUs that can be deemed earned and vested under this award depends on the absolute total shareholder return for the period beginning on October 15, 2024 and ending on December 31, 2027.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
October 15, 2024 Filed Oct 16, 2024 20:12 UTC
Hagan Mark ChristopherChief Information and Digital
GrantRestricted Stock Units · Derivative 18,661 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000056 · wk-form4_1729109524.xml · derivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,661

Underlying: Common Stock · 18,661 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 15, 2024 and vest in two tranches on the first and second anniversaries of the grant date and the grantee's provision of two periods of credited service.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
October 15, 2024 Filed Oct 16, 2024 20:10 UTC
Laughlin Whitney MChief Legal Officer
GrantRestricted Stock Units · Derivative 9,952 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000055 · wk-form4_1729109392.xml · derivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,952

Underlying: Common Stock · 9,952 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Performance Restricted Stock Units ("PRSU") identified in this row were granted on October 15, 2024 and will be eligible for vesting based upon the achievement of a performance requirement. The ultimate number of PRSUs that can be deemed earned and vested under this award depends on the absolute total shareholder return for the period beginning on October 15, 2024 and ending on December 31, 2027.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
October 15, 2024 Filed Oct 16, 2024 20:10 UTC
Laughlin Whitney MChief Legal Officer
GrantRestricted Stock Units · Derivative 9,952 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000055 · wk-form4_1729109392.xml · derivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,952

Underlying: Common Stock · 9,952 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on October 15, 2024 and vest in two tranches on the first and second anniversaries of the grant date and the grantee's provision of two periods of credited service

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
September 15, 2024 Filed Sep 17, 2024 14:48 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 482 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000052 · wk-form4_1726584493.xml · derivative · entry 3

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 981

Underlying: Common Stock · 482 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on September 15, 2023 and vest in three tranches on each of the first, second, and third anniversaries of the grant date.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
September 15, 2024 Filed Sep 17, 2024 14:48 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 118 $47.14 $5,562.52
Disclosure

SEC source: 0001142750-24-000052 · wk-form4_1726584493.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,047

Read SEC document
September 15, 2024 Filed Sep 17, 2024 14:48 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionCommon Stock 482 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000052 · wk-form4_1726584493.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,165

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 13:56 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 256 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000051 · wk-form4_1723816555.xml · derivative · entry 3

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 256 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on August 15, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F4 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 13:56 UTC
Laughlin Whitney MChief Legal Officer
Tax withholdingCommon Stock 63 $52.44 $3,303.72
Disclosure

SEC source: 0001142750-24-000051 · wk-form4_1723816555.xml · nonDerivative · entry 2

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,683

Read SEC document
August 15, 2024 Filed Aug 16, 2024 13:56 UTC
Laughlin Whitney MChief Legal Officer
Exercise / conversionCommon Stock 256 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000051 · wk-form4_1723816555.xml · nonDerivative · entry 1

Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,746

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common stock acquired on the vesting of Restricted Stock Units.

Read SEC document
July 22, 2024 Filed Jul 23, 2024 20:47 UTC GrantRestricted Stock Units · Derivative 2,235 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000044 · wk-form4_1721767637.xml · derivative · entry 1

Hinton James H. · CIK 0001905630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,235

Underlying: Common Stock · 2,235 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on July 22, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
May 20, 2024 Filed May 21, 2024 19:17 UTC GiftCommon Stock 50 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000041 · wk-form4_1716319030.xml · nonDerivative · entry 1

WHEAT DOUGLAS D · CIK 0001158599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,774

F1 · shares: The reporting person transferred 50 shares of AMN Common Stock as a gift.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:27 UTC Exercise / conversionRestricted Stock Units · Derivative 1,681 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000034 · wk-form4_1713900427.xml · derivative · entry 3

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,681 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:27 UTC GrantRestricted Stock Units · Derivative 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000034 · wk-form4_1713900427.xml · derivative · entry 2

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,019

Underlying: Common Stock · 3,019 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:27 UTC Exercise / conversionCommon Stock 1,681 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000034 · wk-form4_1713900427.xml · nonDerivative · entry 1

Trent-Adams Sylvia · CIK 0001826381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,453

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:25 UTC GrantRestricted Stock Units · Derivative 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000032 · wk-form4_1713900303.xml · derivative · entry 3

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,019

Underlying: Common Stock · 3,019 shares

Expires not disclosed

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. Accordingly, the number of RSUs identified in this row vested on April 19, 2024.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:25 UTC Exercise / conversionRestricted Stock Units · Derivative 1,681 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000032 · wk-form4_1713900303.xml · derivative · entry 2

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,681 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F3 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024.

F4 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:25 UTC Exercise / conversionCommon Stock 1,681 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000032 · wk-form4_1713900303.xml · nonDerivative · entry 1

FOLETTA MARK G · CIK 0001236389 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,254

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs").

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:26 UTC GrantRestricted Stock Units · Derivative 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000033 · wk-form4_1713900367.xml · derivative · entry 1

Fontenot Teri G. · CIK 0001661066 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,019

Underlying: Common Stock · 3,019 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:23 UTC GrantRestricted Stock Units · Derivative 3,019 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000031 · wk-form4_1713900228.xml · derivative · entry 1

Jones Daphne E · CIK 0001475924 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,019

Underlying: Common Stock · 3,019 shares

Expires not disclosed

F1 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. At the reporting owner's irrevocable election, the number of RSUs identified in this row will settle on the date of the director's separation from service with the Company.

F3 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:22 UTC Exercise / conversionRestricted Stock Units · Derivative 22,575 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000030 · wk-form4_1713900120.xml · derivative · entry 6

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,575 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: The Restricted Stock Units were granted pursuant to the AMN Healthcare Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.

F10 · derivative.exercise_date: The RSUs were granted on April 18, 2012 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's 2013 Annual Meeting of Shareholders.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 19:22 UTC Exercise / conversionRestricted Stock Units · Derivative 6,275 $0.00 $0.00
Disclosure

SEC source: 0001142750-24-000030 · wk-form4_1713900120.xml · derivative · entry 5

Marsh Martha H. · CIK 0001500281 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,275 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock

F8 · derivative.exercise_date: The Restricted Stock Units were granted on September 21, 2010 and vest in the incremental amount of 33% on the earlier of (i) April 13, 2011 or (ii) the date of the Company's 2011 Annual Meeting of Stockholders; 34% on the earlier of (i) April 13, 2012 or (ii) the date of the Company's 2012 Annual Meeting of Stockholders; and 33% on the earlier of (i) April 13, 2013 or (ii) the date of the Company's 2013 Annual Meeting of Stockholders.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.